REGENERON PHARMACEUTICALS, INC. Insider Trading for December 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for December 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 3,450 | 179,504 | 10,326 | |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 21.25 | 675 | 14,344 | 500 | |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 362.45 | 200 | 72,490 | 7,096 | 7.3 K to 7.1 K (-2.74 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 361.65 | 100 | 36,165 | 7,296 | 7.4 K to 7.3 K (-1.35 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 360.40 | 500 | 180,200 | 7,396 | 7.9 K to 7.4 K (-6.33 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 359.38 | 200 | 71,876 | 7,896 | 8.1 K to 7.9 K (-2.47 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 358.27 | 200 | 71,654 | 8,096 | 8.3 K to 8.1 K (-2.41 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 357.50 | 200 | 71,500 | 8,296 | 8.5 K to 8.3 K (-2.35 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 356.27 | 348 | 123,982 | 8,496 | 8.8 K to 8.5 K (-3.93 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 355.14 | 100 | 35,514 | 8,844 | 8.9 K to 8.8 K (-1.12 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 21.25 | 675 | 14,344 | 8,944 | 8.3 K to 8.9 K (+8.16 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 364.42 | 1,602 | 583,801 | 8,269 | 9.9 K to 8.3 K (-16.23 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 3,450 | 179,504 | 9,871 | 6.4 K to 9.9 K (+53.73 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 94,048 | 1,580,006 | 0 | |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 150,000 | 2,520,000 | 94,048 | |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 602,594 | 483.6 K to 602.6 K (+24.61 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 0 | 119 K to 0 (-100.00 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 48,192 | 18,183,324 | 118,993 | 167.2 K to 119 K (-28.83 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 94,048 | 1,580,006 | 167,185 | 73.1 K to 167.2 K (+128.59 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 76,863 | 29,001,179 | 73,137 | 150 K to 73.1 K (-51.24 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 150,000 | 2,520,000 | 150,000 | 0 to 150 K |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 381.40 | 36,273 | 13,834,522 | 36,273 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 521 | 0 | 147,413 | 147.9 K to 147.4 K (-0.35 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 382.32 | 6 | 2,294 | 2,304 | 2.3 K to 2.3 K (-0.26 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 16,161 | 0 | 314,877 | 331 K to 314.9 K (-4.88 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 19,202 | 0 | 331,038 | 350.2 K to 331 K (-5.48 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 37,209 | 0 | 350,240 | 387.4 K to 350.2 K (-9.60 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 12,500 | 0 | 387,449 | 399.9 K to 387.4 K (-3.13 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 381.40 | 129,013 | 49,205,558 | 129,013 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,176 | 0 | 483,601 | 484.8 K to 483.6 K (-0.24 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 3,211 | 0 | 484,777 | 488 K to 484.8 K (-0.66 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 487,988 | 487.1 K to 488 K (+0.17 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 487,141 | 386 K to 487.1 K (+26.22 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 385,954 | 86.8 K to 386 K (+344.55 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 86,820 | 486.8 K to 86.8 K (-82.17 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 486,820 | 244.7 K to 486.8 K (+98.97 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 244,670 | 155.4 K to 244.7 K (+57.44 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 155,406 | 331.6 K to 155.4 K (-53.14 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 331,629 | 155.4 K to 331.6 K (+113.40 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 159,324 | 69.9 K to 159.3 K (+127.94 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 569,897 | 568 K to 569.9 K (+0.34 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 612,936 | 569.6 K to 612.9 K (+7.61 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 75,036 | 176.2 K to 75 K (-57.42 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 176,223 | 0 to 176.2 K |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 24,643 | 0 | 0 | 24.6 K to 0 (-100.00 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 24,643 | 323.8 K to 24.6 K (-92.39 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 323,777 | 500 K to 323.8 K (-35.24 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 0 | 847 to 0 (-100.00 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 847 | 243 K to 847 (-99.65 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 500,847 | 590.1 K to 500.8 K (-15.13 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 500,000 | 589.4 K to 500 K (-15.17 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 500,000 | 501.9 K to 500 K (-0.38 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 500,000 | 543.3 K to 500 K (-7.98 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 381.40 | 129,013 | 49,205,558 | 129,013 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 16.80 | 125,000 | 2,100,000 | 0 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 16.80 | 187,500 | 3,150,000 | 125,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.31 | 64,052 | 24,167,460 | 423,962 | 488 K to 424 K (-13.13 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 16.80 | 125,000 | 2,100,000 | 488,014 | 363 K to 488 K (+34.43 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.31 | 96,079 | 36,251,567 | 363,014 | 459.1 K to 363 K (-20.93 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 16.80 | 187,500 | 3,150,000 | 459,093 | 271.6 K to 459.1 K (+69.04 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | A | 381.40 | 11,400 | 4,347,960 | 11,400 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 2,950 | 0 | 2,950 | 0 to 3 K |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 2,950 | 0 | 1,397 | 4.3 K to 1.4 K (-67.86 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 50 | 0 | 4,347 | 4.3 K to 4.3 K (+1.16 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Grant | A | 0.00 | 5,000 | 0 | 6,421 | 1.4 K to 6.4 K (+351.86 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 50 | 0 | 1,421 | 1.5 K to 1.4 K (-3.40 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 381.40 | 20,000 | 7,628,000 | 20,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 381.40 | 20,000 | 7,628,000 | 20,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Grant | A | 0.00 | 12,500 | 0 | 17,348 | 4.8 K to 17.3 K (+257.84 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | A | 381.40 | 10,000 | 3,814,000 | 10,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Grant | A | 0.00 | 10,000 | 0 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 381.40 | 20,000 | 7,628,000 | 20,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 381.40 | 46,250 | 17,639,750 | 46,250 |